10 Longevity Myths, Debunked: What the Evidence Actually Says
Matt Kaeberlein walks through the first ten longevity myths from his social series, from "you can measure biological age" to "peptides are natural and safe". The recurring theme: most of what is marketed as longevity science is either a correlation dressed up as a measurement, or a molecule with far weaker evidence than its popularity suggests. The things that genuinely move the needle remain unglamorous — diet, exercise, sleep, relationships.
Overview
This episode collects the first ten entries in Matt Kaeberlein's ongoing longevity myths series and expands each one into a longer conversation. He opens with the most consequential misunderstanding in the field: nobody can directly measure biological age, because nobody yet understands what it is at a cellular level, so every commercial "age clock" is estimating a correlate rather than the thing itself. From there he explains why he prefers mortality-risk estimators built on blood biomarkers and functional measures, since those point at something you can actually act on.
Several myths are aimed at the industry rather than the public — the belief that FDA approval hinges on aging being classified as a disease, the claim that caloric restriction only works by preventing cancer, and the assumption that aging research is generously funded when it receives roughly half a percent of the NIH budget. Others target consumer beliefs directly: resveratrol has been tested more than almost any longevity molecule and the pooled result is zero, genetics accounts for well under half of human longevity, and chronological age is never a reason to stop trying.
He is equally blunt about the tools associated with his own name, arguing that neither supplements nor rapamycin belongs in the core of a longevity approach. The final myth, that peptides are natural and therefore safe, gets the sharpest treatment: most of those circulating in the wellness space are not naturally occurring and have never been rigorously tested. The through-line is a call for proportion — enthusiasm should track evidence, and lifestyle remains the foundation everything else sits on top of.
Key quotes
5We have no tool that allows us to directly measure biological age.
You can have a fantastic longevity protocol and not take a single supplement.
Resveratrol is the most debunked longevity molecule ever.
Nine of the top 10 causes of death in the United States have biological age as their greatest risk factor.
Most of the ones that are used in the space are not naturally occurring.
Key ideas
9Biological age is estimated, never measured
Length has a ruler; biological age has nothing equivalent, because the cellular definition is still open. Epigenetic clocks read methylation marks that correlate with chronological age or mortality risk, which makes them correlations to a correlation.
Prefer estimators you can act on
Mortality-risk tools built from twelve to twenty-five blood, physiological and survey features perform at least as well as epigenetic clocks. Their advantage is actionability: if a marker like HbA1c is driving the estimate, there is something concrete to work on.
Supplements sit outside the core
The defensible use case is narrow — measure a marker, find it outside the optimal range, supplement back into range. Vitamin D, omega-3 and B vitamins fit that pattern; almost nothing justifies a population-wide blanket recommendation.
Late is not too late
Two decades of animal work show interventions that slow biological aging still work when started late in life, sometimes improving declines rather than merely delaying them. There is no biological principle that closes the door at a given age.
The disease-classification debate is a distraction
Regulators care about safety and about demonstrated improvement in quality or quantity of life for a defined group, not about whether aging carries a disease label. The more interesting downstream question is reimbursement, which is a separate conversation.
Aging biology is dramatically underfunded
Roughly half of one percent of the NIH budget goes to the biology of aging, while age is the leading risk factor for nine of the ten top causes of death. Even the highest-profile private initiatives are small against that backdrop.
Environment outweighs genetics
Estimates of the genetic contribution to human longevity range from about fifteen percent to something approaching fifty, complicated by historical extrinsic mortality. Whatever the exact figure, it is under half — which means most of the trajectory is in your hands.
Caloric restriction is broader than cancer
It remains the most studied non-genetic lifespan intervention in laboratory animals, exceeding rapamycin in magnitude in mice. It does reduce cancer risk, but it also slows aging in brain, heart, liver, kidney and every other tissue examined.
A hierarchy of levers, lifestyle first
Diet, exercise, sleep, relationships and mindfulness affect every age-related condition because they act on aging biology itself. Hormonal correction is often a larger lever than rapamycin, and supplements sit further down still.
Practical takeaways
7- 1
Read age clocks as estimates 3:10
Treat any biological age number as an estimate of a correlate, not a measurement. Track how it moves over time rather than anchoring on a single figure.
- 2
Track functional measures 6:10
Grip strength and cardiorespiratory fitness are measurable, improvable, and known to matter. They give you feedback a methylation readout cannot.
- 3
Measure before you supplement 9:00
Reserve supplementation for markers you have actually tested and found outside the optimal range, then re-test. Skip anything justified only by a general claim.
- 4
Age is not a reason to stop 12:20
Starting later still produces meaningful change; strength work begun in the seventies still builds capacity. Choose the version of the habit that fits your current condition.
- 5
Retire resveratrol from the shortlist 18:40
The lifespan literature nets out at zero and is likely skewed positive by publication bias. Redirect that budget and attention toward measures with clearer support.
- 6
Family history is context, not destiny 27:40
A long-lived grandparent and a difficult family history should change neither your effort nor your habits. Use genetic risk information to target prevention, not to predict outcomes.
- 7
Treat peptides like medications 36:20
Naturally occurring is not the same as safe, and most peptides circulating in the wellness space are neither. Anything in this category belongs in a supervised medical conversation.
Topics & chapters
15Why a myths series
The first ten myths are not a ranked list but the ones that surfaced first. Kaeberlein expects the series to continue indefinitely.
Myth 1: biological age can be measured
There is no direct measurement tool, because the underlying biology is not yet defined. Marketing language routinely blurs estimation into measurement.
What epigenetic clocks actually read
Commercial tests detect DNA methylation patterns correlated with chronological age, mortality risk or disease risk. That makes them correlations to a correlation.
Better and more actionable estimators
Blood-based and functional mortality-risk models perform comparably or better while pointing at modifiable inputs. Functional measures like grip strength and cardiorespiratory fitness get a strong endorsement.
Myth 2: supplements are core
A narrow set earns a place through measurement and correction into range. Lifestyle factors, not capsules, form the core of a longevity approach.
Myth 3: I am too old to bother
Everyone can move onto a better healthspan trajectory regardless of age. Animal studies show late-life interventions still produce benefit.
Myth 4: aging must be a disease first
Approval hinges on safety and on measurable improvement in quality or quantity of life, not on classification. The label matters more for insurance reimbursement than for regulators.
Myth 5: resveratrol is a longevity molecule
Meta-analysis across dozens of lifespan studies nets to zero, with positive publication bias on top. High-profile voices continue to promote it regardless.
Myth 6: aging research is well funded
Roughly half a percent of the NIH budget addresses the greatest risk factor behind nine of the top ten causes of death. Private initiatives are small relative to that gap.
How the money is actually split
More than half of the aging institute's budget goes to Alzheimer's research, with a small fraction for aging biology itself. Cancer research receives more than an order of magnitude more.
Myth 7: longevity is mostly genetic
Estimates range from about fifteen to near fifty percent, complicated by historical extrinsic mortality. Environment and lifestyle carry the larger share.
Myth 8: caloric restriction only prevents cancer
It is the most studied non-genetic lifespan intervention in laboratory animals and does reduce cancer risk. It also slows aging across brain, heart, liver, kidney and other tissues.
Myth 9: rapamycin is core
Confidence in the mouse data does not transfer to humans, where the evidence remains open. Nothing unproven belongs in the core of a longevity approach.
Ordering the levers
Lifestyle acts on aging biology itself, which is why it touches every age-related condition. Hormonal correction is often a bigger lever than rapamycin, with supplements further down.
Myth 10: peptides are natural and safe
Most peptides used in the wellness space are chemically modified or fragments never found intact in the body. Effects are dose-dependent and testing is largely absent, so they deserve pharmaceutical-grade caution.